Evidence map›Paper›PMID 33606193›Full record

ArticleClinical reviews in allergy & immunology2021

Pathways of Neutrophil Granulocyte Activation in Hereditary Angioedema with C1 Inhibitor Deficiency.

Erika Kajdácsi, Nóra Veszeli, Blanka Mező, Zsófia Jandrasics, Kinga Viktória Kőhalmi, Anne Lise Ferrara, László Cervenak, Lilian Varga, Henriette Farkas

Open access · hybridAbstract read
In one paragraph

Article in Clinical reviews in allergy & immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Guideline
  2. Mast cell mediators in hereditary angioedema.Orphanet journal of rare diseases · 2026
    Article
  3. Increased thromboinflammatory load in hereditary angioedema.Clinical and experimental immunology · 2023
    Article
  4. Article
  5. Review
  6. Article
  7. A novel pathogenetic factor of laryngeal attack in hereditary angioedema? Involvement of protease activated receptor 1.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2022
    Article
  8. Frontiers in allergy · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Erika KajdácsiResearch Laboratory, Department of Internal Medicine and Hematology, Semmelweis University, 46 Szentkirályi str, 1088, Budapest, Hungary.ORCID http://orcid.org/0000-0003-0739-2193
Nóra VeszeliMTA-SE Research Group of Immunology and Hematology, Hungarian Academy of Sciences and Semmelweis University, Budapest, Hungary.ORCID http://orcid.org/0000-0002-7647-2173
Blanka MezőMTA-SE Research Group of Immunology and Hematology, Hungarian Academy of Sciences and Semmelweis University, Budapest, Hungary.ORCID http://orcid.org/0000-0002-9750-1682
Zsófia JandrasicsResearch Laboratory, Department of Internal Medicine and Hematology, Semmelweis University, 46 Szentkirályi str, 1088, Budapest, Hungary.
Kinga Viktória KőhalmiHungarian Angioedema Center of Reference and Excellence, Department of Internal Medicine and Haematology, Semmelweis University, Budapest, Hungary.ORCID http://orcid.org/0000-0002-7381-6866
Anne Lise FerraraCenter for Basic and Clinical Immunology Research (CISI), Department of Translational Medical Science, University of Naples "Federico II", Napoli, Italy.ORCID http://orcid.org/0000-0003-1839-8873
László CervenakResearch Laboratory, Department of Internal Medicine and Hematology, Semmelweis University, 46 Szentkirályi str, 1088, Budapest, Hungary.ORCID http://orcid.org/0000-0003-0166-8697
Lilian VargaResearch Laboratory, Department of Internal Medicine and Hematology, Semmelweis University, 46 Szentkirályi str, 1088, Budapest, Hungary.ORCID http://orcid.org/0000-0002-5484-364X
Henriette FarkasResearch Laboratory, Department of Internal Medicine and Hematology, Semmelweis University, 46 Szentkirályi str, 1088, Budapest, Hungary. farkas.henriette@med.semmelweis-univ.hu.
Semmelweis University · HUUniversity of Naples Federico II · IT

Funding

Nemzeti Kutatási, Fejlesztési és Innovaciós Alap K124557
6 · The paper itself

Abstract

Hereditary angioedema (HAE) with C1-inhibitor deficiency belongs to bradykinin-mediated angioedemas. It is characterized by recurrent subcutaneous and/or submucosal swelling episodes (HAE attacks) and erythema marginatum skin rash as a pre-attack (prodromal) phase. HAE attacks were shown to be accompanied by peripheral blood neutrophilia. We aimed to find molecular mechanisms that may explain the distinct role of neutrophil granulocytes in HAE. Plasma levels of blood cells and factors related to neutrophil activation (cytokines, chemokines, chemotactic factors, enzymes, and neutrophil extracellular trap) were measured in plasma samples obtained from patients during symptom-free periods (n = 77), during prodromal phase (n = 8) and attacks (n = 14), during a spontaneously resolved attack (n = 1), and in healthy controls (n = 79). Higher counts of white blood cells, lymphocytes, and neutrophil granulocytes were found in symptom-free patients compared with controls; these cell counts were elevated further during HAE attacks. The level of chemokine (C-C motif) ligand 5, monocyte chemoattractant protein-1, and myeloperoxidase were also higher in the symptom-free patients than in the controls. Levels of monocyte chemoattractant protein-1, leukotriene B4, neutrophil elastase, and myeloperoxidase were elevated during attacks. During erythema marginatum, white blood cells and monocyte count and levels of interleukin 8 were elevated compared with symptom-free period. Similar changes were detected during the attack follow-up. We conclude that the activation of NGs in symptom-free periods and a further increase observed during attacks suggests that NGs may be involved in the pathomechanism of HAE with C1-INH deficiency.

Indexed as

Angioedemas, HereditaryChemokine CCL2Complement C1 Inhibitor ProteinErythemaHumansNeutrophil ActivationNeutrophilsPeroxidaseSkin Diseases, GeneticChemokine CCL2Complement C1 Inhibitor ProteinPeroxidaseBradykininC1-inhibitorCytokinesErythema marginatumHereditary angioedemaNeutrophils

Identifiers

PMID33606193
PMCPMC8272702
OpenAlexW3131258807

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.